Special collections

Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade
Ming Zheng

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005670; DOI: 10.1136/jitc-2022-005670
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study
Brendan D Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries, Lynn Feun, Kim A Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang, Anlong Li, Robert H I Andtbacka

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005224; DOI: 10.1136/jitc-2022-005224
Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
Lunan Liu, Chao Ma, Zhuoyu Zhang, Matthew T Witkowski, Iannis Aifantis, Saba Ghassemi, Weiqiang Chen

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005360; DOI: 10.1136/jitc-2022-005360
Systemic cellular viroimmunotherapy for canine high-grade gliomas
Ana Cloquell, Isidro Mateo, Stefano Gambera, Martí Pumarola, Ramon Alemany, Javier García-Castro, Ana Judith Perisé-Barrios

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005669; DOI: 10.1136/jitc-2022-005669
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies
Joshua T Kowalczyk, Kellsye P Fabian, Michelle R Padget, Diana C Lopez, Austin TK Hoke, Clint T Allen, Mario Hermsen, Nyall R London,, James W Hodge

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005752; DOI: 10.1136/jitc-2022-005752
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma
Qiangda Chen, Hanlin Yin, Siyao Liu, Sami Shoucair, Ni Ding, Yuan Ji, Jicheng Zhang, Dansong Wang, Tiantao Kuang, Xuefeng Xu, Jun Yu, Wenchuan Wu, Ning Pu, Wenhui Lou

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005798; DOI: 10.1136/jitc-2022-005798
Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
Tamara A Sussman, Rebecca Knackstedt, Wei Wei, Pauline Funchain, Brian R Gastman

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e004994; DOI: 10.1136/jitc-2022-004994
Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
Guangshun Sun, Hanyuan Liu, Jie Zhao, Jinyu Zhang, Tian Huang, Guoqiang Sun, Siqi Zhao, Zihao Zhang, Hengsong Cao, Dawei Rong, Xiangyi Kong, Qinghua Ji, Li Liu, Xuehao Wang, Weiwei Tang, Yongxiang Xia

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005655; DOI: 10.1136/jitc-2022-005655
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers
Anaïs Jiménez-Reinoso, Néstor Tirado, Alba Martinez-Moreno, Víctor M Díaz, Marina García-Peydró, Oana Hangiu, Laura Díez-Alonso, Ángela Albitre, Petronila Penela, Maria L Toribio, Pablo Menéndez, Luis Álvarez-Vallina, Diego Sánchez Martínez

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005333; DOI: 10.1136/jitc-2022-005333
Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy
Philip C Simister, Ellen C Border, João F Vieira, Nicholas J Pumphrey

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004600; DOI: 10.1136/jitc-2022-004600

Main menu

Special collections

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Special collections

Pages